Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Epilepsy Behav ; 140: 109106, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36745963

RESUMEN

The exact mechanism of a ketogenic diet (KD) as a suitable alternative therapeutic approach for drug-resistant epilepsy (DRE) in alleviating seizures is not yet fully understood. The present study aimed to evaluate the role of the KD in reducing oxidative stress (OS) by increasing the ketone body beta-hydroxybutyrate (BHB) and Arachidonic acid (ARA), an essential polyunsaturated fatty acid, as a possible mechanism in relieving seizure attacks in children with DRE. Forty children with refractory epilepsy were included in the present study. The serum levels of BHB, ARA, and OS markers, malondialdehyde (MDA), and 8-hydroxyl-deoxyguanosine (8-OHdG), were evaluated in children with DRE and compared before and after the three months of KD therapy. Thirty-four of 40 included children could complete the three-month KD therapy. Twenty-one (61.76%) patients had more than a 50% reduction in seizure frequency after the KD (responders). The remaining 13 children were considered non-responders to the diet. The serum levels of ARA and BHB significantly (p < 0.05) increased after the KD therapy. The serum levels of OS parameters MDA and 8-OHdG before the diet therapy were significantly (p < 0.05) higher than those after the administration. The serum levels of BHB and MDA after the KD therapy in the responders were respectively higher and lower than those in the non-responders (p < 0.001). Ketogenic diet might reduce brain OS by increasing BHB and ARA. The role of BHB in diminishing OS and seizure might be more remarkable than ARA.


Asunto(s)
Dieta Cetogénica , Epilepsia Refractaria , Epilepsia , Niño , Humanos , Dieta Cetogénica/efectos adversos , Ácido 3-Hidroxibutírico , Ácido Araquidónico , Convulsiones , Resultado del Tratamiento
2.
Nutr Neurosci ; 24(4): 307-316, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31241011

RESUMEN

The ketogenic diet (KD) has been used for a long time as a therapeutic approach for drug-resistant epilepsy. It is a high-fat, low-carbohydrate, and adequate protein diet. There are various types of KD with some differences in their compositions that mainly include classic KD, medium-chain triglyceride diet, modified Atkins diet, and low glycemic index treatment. The anti-seizure mechanisms of KDs have not yet completely understood but, some possible mechanisms can be theorized. The aim of the present study was to review the various types of KD and explain the probable biochemical mechanisms involved in its anti-seizure property.


Asunto(s)
Dieta Cetogénica , Epilepsia Refractaria , Convulsiones , Dieta con Restricción de Grasas , Dieta Rica en Proteínas y Pobre en Hidratos de Carbono , Epilepsia Refractaria/tratamiento farmacológico , Índice Glucémico , Humanos , Convulsiones/tratamiento farmacológico , Convulsiones/prevención & control , Resultado del Tratamiento , Triglicéridos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA